Erratum to: GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation (Scientific Reports, (2018), 8, 1, (14529), 10.1038/s41598-018-32797-1)

Elena Smolensky Koganov, Alan D. Michelson, Ivan B. Yanachkov, Milka I. Yanachkova, George E. Wright, Karin Przyklenk, Andrew L. Frelinger

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Erratum to: GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation (Scientific Reports, (2018), 8, 1, (14529), 10.1038/s41598-018-32797-1)'. Together they form a unique fingerprint.

Medicine & Life Sciences